Ovarian Cancer Metastatic
4 clinical trials · Condition
◉ Watch Ovarian Cancer Metastatic
| Record | Firm | Date |
|---|---|---|
| Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical Study (NCT07311577) | Jiangsu Cancer Institute & Hospital | 2026-01-01 |
| Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors (NCT07444814) | Whitehawk Therapeutics, Inc. | 2025-12-19 |
| O-RADS MRI System on Early Detection of Ovarian Cancer (NCT07009743) | Shanghai Gynecologic Oncology Group | 2025-01-01 |
| OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial) (NCT04389229) | Immetacyte Ltd | 2020-07-01 |
Track Ovarian Cancer Metastatic automatically
Every clearance here is in the API, with alerts when new ones post.